Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria A Pabon

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
JACC. Heart Failure|October 10, 2024
Race in Heart Failure: A Pooled Participant-Level Analysis of the Global PARADIGM-HF and PARAGON-HF TrialsHenri Lu, Brian L Claggett, Milton Packer, et al.
European Journal of Heart Failure|December 18, 2024
Mortality after high-risk myocardial infarction over the last 20 years: Insights from the VALIANT and PARADISE-MI trialsAlberto Foà, Maria A Pabon, Eugene Braunwald, et al.
JAMA Cardiology|March 30, 2025
Mode of Death in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The FINEARTS-HF Randomized Clinical TrialAkshay S Desai, Pardeep S Jhund, Muthiah Vaduganathan, et al.
European Journal of Heart Failure|September 20, 2024
In-hospital course of patients with heart failure with improved ejection fraction in the DELIVER trialMaria A Pabon, Muthiah Vaduganathan, Brian L Claggett, et al.
JCI Insight|July 13, 2018
Circulating RIPK3 levels are associated with mortality and organ failure during critical illnessKevin C Ma, Edward J Schenck, Ilias I Siempos, et al.
European Journal of Heart Failure|December 15, 2024
Effect of sacubitril/valsartan in heart failure with preserved ejection fraction across the age spectrum in PARAGON-HFXiaowen Wang, Orly Vardeny, Brian Claggett, et al.
JACC. Heart Failure|August 20, 2025
Achieved Ejection Fraction and Effects of Dapagliflozin in Heart Failure With Improved Ejection FractionSara R O Siqueira, Maria A Pabon, Muthiah Vaduganathan, et al.
Journal of the American College of Cardiology|April 9, 2025
Genetic Risk and First-Trimester Cardiovascular Health Predict Hypertensive Disorders of Pregnancy in Nulliparous WomenVineetha Mathew, Raiyan R Khan, Amanda R Jowell, et al.
Circulation. Heart Failure|November 8, 2025
Effect of Aficamten in Women Compared with Men with Obstructive Hypertrophic Cardiomyopathy in SEQUOIA-HCMXiaowen Wang, Maria A Pabon, Tracy T Makuvire, et al.
American Journal of Preventive Cardiology|July 3, 2026
Preconception cardiometabolic markers and odds of developing adverse pregnancy outcomes: Results from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)Maria A Pabon, Danielle N Tapp, Madison Pico, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
JACC. Heart Failure|October 10, 2024
Race in Heart Failure: A Pooled Participant-Level Analysis of the Global PARADIGM-HF and PARAGON-HF TrialsHenri Lu, Brian L Claggett, Milton Packer, et al.
European Journal of Heart Failure|December 18, 2024
Mortality after high-risk myocardial infarction over the last 20 years: Insights from the VALIANT and PARADISE-MI trialsAlberto Foà, Maria A Pabon, Eugene Braunwald, et al.
JAMA Cardiology|March 30, 2025
Mode of Death in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The FINEARTS-HF Randomized Clinical TrialAkshay S Desai, Pardeep S Jhund, Muthiah Vaduganathan, et al.
European Journal of Heart Failure|September 20, 2024
In-hospital course of patients with heart failure with improved ejection fraction in the DELIVER trialMaria A Pabon, Muthiah Vaduganathan, Brian L Claggett, et al.
JCI Insight|July 13, 2018
Circulating RIPK3 levels are associated with mortality and organ failure during critical illnessKevin C Ma, Edward J Schenck, Ilias I Siempos, et al.
European Journal of Heart Failure|December 15, 2024
Effect of sacubitril/valsartan in heart failure with preserved ejection fraction across the age spectrum in PARAGON-HFXiaowen Wang, Orly Vardeny, Brian Claggett, et al.
JACC. Heart Failure|August 20, 2025
Achieved Ejection Fraction and Effects of Dapagliflozin in Heart Failure With Improved Ejection FractionSara R O Siqueira, Maria A Pabon, Muthiah Vaduganathan, et al.
Journal of the American College of Cardiology|April 9, 2025
Genetic Risk and First-Trimester Cardiovascular Health Predict Hypertensive Disorders of Pregnancy in Nulliparous WomenVineetha Mathew, Raiyan R Khan, Amanda R Jowell, et al.
Circulation. Heart Failure|November 8, 2025
Effect of Aficamten in Women Compared with Men with Obstructive Hypertrophic Cardiomyopathy in SEQUOIA-HCMXiaowen Wang, Maria A Pabon, Tracy T Makuvire, et al.
American Journal of Preventive Cardiology|July 3, 2026
Preconception cardiometabolic markers and odds of developing adverse pregnancy outcomes: Results from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)Maria A Pabon, Danielle N Tapp, Madison Pico, et al.
Pageof 4